Sionna Therapeutics, Inc.$21.43 %
Analyst Rating: Hold
Stock Details
CEO
Michael Cloonan
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
41
Address
21 Hickory Drive Suite 500, Waltham, MA, 02451
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Sionna Therapeutics, Inc. $21.43
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results